Tela Bio Inc (NASDAQ:TELA) — Market Cap & Net Worth
Market Cap & Net Worth: Tela Bio Inc (TELA)
Tela Bio Inc (NASDAQ:TELA) has a market capitalization of $32.68 Million ($32.68 Million) as of August 3, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #23402 globally and #5040 in its home market, demonstrating a 2.67% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Tela Bio Inc's stock price $0.73 by its total outstanding shares 44766146 (44.77 Million). Review TELA current and long-term liabilities to assess the company's total debt and financial obligations.
Tela Bio Inc Market Cap History: 2019 to 2026
Tela Bio Inc's market capitalization history from 2019 to 2026. Data shows change from $579.72 Million to $32.68 Million (-35.06% CAGR).
Index Memberships
Tela Bio Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.46 Trillion | 0.00% | #669 of 976 |
|
NASDAQ Composite
IXIC
|
$40.26 Trillion | 0.00% | #2220 of 3165 |
Weight: Tela Bio Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Tela Bio Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Tela Bio Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.66x
Tela Bio Inc's market cap is 0.66 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $579.72 Million | $15.45 Million | -$22.43 Million | 37.53x | N/A |
| 2020 | $673.28 Million | $18.21 Million | -$28.79 Million | 36.97x | N/A |
| 2021 | $573.01 Million | $29.46 Million | -$33.28 Million | 19.45x | N/A |
| 2022 | $514.81 Million | $41.42 Million | -$44.30 Million | 12.43x | N/A |
| 2023 | $296.35 Million | $58.45 Million | -$46.66 Million | 5.07x | N/A |
| 2024 | $135.19 Million | $69.30 Million | -$37.84 Million | 1.95x | N/A |
| 2025 | $52.82 Million | $80.28 Million | -$38.83 Million | 0.66x | N/A |
Competitor Companies of TELA by Market Capitalization
Companies near Tela Bio Inc in the global market cap rankings as of August 3, 2026.
Key companies related to Tela Bio Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #114 globally with a market cap of $183.80 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #189 globally with a market cap of $124.64 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #233 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #238 globally with a market cap of $103.60 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #114 | Abbott Laboratories | NYSE:ABT | $183.80 Billion | $105.70 |
| #189 | Stryker Corporation | NYSE:SYK | $124.64 Billion | $325.70 |
| #233 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #238 | Medtronic PLC | NYSE:MDT | $103.60 Billion | $85.39 |
Tela Bio Inc Historical Marketcap From 2019 to 2026
Between 2019 and today, Tela Bio Inc's market cap moved from $579.72 Million to $ 32.68 Million, with a yearly change of -35.06%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $32.68 Million | -38.14% |
| 2025 | $52.82 Million | -60.93% |
| 2024 | $135.19 Million | -54.38% |
| 2023 | $296.35 Million | -42.43% |
| 2022 | $514.81 Million | -10.16% |
| 2021 | $573.01 Million | -14.89% |
| 2020 | $673.28 Million | +16.14% |
| 2019 | $579.72 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 3rd, 2026 the market cap of Tela Bio Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $32.68 Million USD |
| MoneyControl | $32.68 Million USD |
| MarketWatch | $32.68 Million USD |
| marketcap.company | $32.68 Million USD |
| Reuters | $32.68 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Tela Bio Inc
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue… Read more